Covid-19

XORTX is a biopharmaceutical company focused on developing drugs that could reduce serum acid uric levels. An Initiation Equity Research Report on XORTX was published by eResearch on August 16, 2020. [more]

Recently, the Trump administration ordered more than 500,000 doses of Remdesivir, fully clearing out Gilead’s supply for July and taking 90% of Gilead’s production in August and September, leaving no supply for the rest of the world. [more]

At the PGC Conference, the topic of COVID-19 and its effects on the gaming industry was brought up numerous times, as the industry experienced a surge in user activity and engagement due to consumers staying isolated at home with more free time. [more]

BLM report showed the U.S. economy added 2.5 million jobs in May and unemployment rate declined to 13.3% instead of rising as it was expected; stock markets responded positively to the news. [more]

After the fiscal year end, the Company experienced “unprecedented” consumer demand because of the COVID-19 pandemic. OG is still on track to open its 5th store, in the Leaside neighborhood of Toronto, in early 2021. [more]

As the coronavirus negatively affects the business world and companies cut or pull guidance, here are three companies, backed by recently released financial results, which have reaffirmed growth guidance for 2020 – Sangoma, Trulieve and Xebec. [more]

Another 2.1 million Americans filed for unemployment claims last week, bringing the 10-week total to over 40 million. Although the S&P 500 finished up 4.5% in May, the VIX rebound back above 30. [more]

Although the lockdowns forced several retail companies to close physical stores and focus on building online sales, the industry has already been on a transition out of brick-and-mortar operations as Best Buy (NYSE: BBY), Target (NYSE: TGT), and Walmart (NYSE: WMT) focus on their e-commerce platforms. [more]